Introduction 7.622384
: 2.5079741
Ċ 1.0427654
Mel 15.966974
an 3.3220403
oma 1.1363511
, 3.6628957
Ġa 2.3116908
Ġform 3.2224226
Ġof 0.009147591
Ġskin 0.8267708
Ġcancer 0.020988163
, 0.37020788
Ġhas 2.7888427
Ġexperienced 7.250446
Ġsignificant 3.948777
Ġadvancements 3.1377864
Ġin 0.53373176
Ġtreatments 4.5655355
Ġin 2.8050857
Ġrecent 0.45196947
Ġyears 0.07992855
. 0.35916942
ĠAmong 5.896518
Ġthese 1.6004409
Ġadvancements 0.9704213
, 0.72897446
Ġimmune 7.4157248
Ġcheckpoint 2.1538386
Ġinhibitors 0.3043065
Ġand 3.9657133
Ġadj 5.072295
u 1.0027893
vant 0.01687587
Ġtherapies 1.115271
Ġhave 0.57531977
Ġemerged 2.4126081
Ġas 0.15171686
Ġpromising 2.1464102
Ġapproaches 3.8662035
. 1.5215654
ĠThis 3.6242526
Ġessay 6.3396363
Ġexplores 3.2572246
Ġthe 0.5376778
Ġpotential 2.4459314
Ġbenefits 2.694227
Ġof 0.4746279
Ġthese 1.4056827
Ġtreatments 2.5473146
, 1.975071
Ġtheir 3.2973652
Ġimplications 5.954418
Ġfor 0.542503
Ġpatients 2.2415376
Ġat 5.791862
Ġdifferent 5.2990785
Ġstages 0.06421398
Ġof 0.095551684
Ġmelan 3.902585
oma 0.0058930167
, 3.113325
Ġand 0.14488679
Ġtheir 1.5729789
Ġimpact 3.3435776
Ġon 0.07190041
Ġimproving 7.7776904
Ġsurvival 1.460864
Ġrates 1.0848581
. 0.69636494
ĠFurthermore 5.6534085
, 0.0044210707
Ġit 1.8632976
Ġwill 3.2893438
Ġdraw 6.2900085
Ġon 1.7298255
Ġresearch 3.769837
Ġevidence 3.6400056
Ġand 2.539845
Ġanalyze 8.235346
Ġthe 0.7812002
Ġcase 6.779799
Ġof 1.0411031
ĠMr 8.080696
. 0.06653538
ĠB 4.5797396
Ġas 7.606492
Ġan 0.93647504
Ġillust 3.5094004
rative 0.005923836
Ġexample 0.831316
. 1.6083212
Ċ 0.4555258
Body 12.632627
: 1.9783839
Ċ 1.1670969
I 4.9101706
. 2.6493495
ĠImm 8.741288
une 0.004083288
ĠCheck 3.1930523
point 0.15722226
ĠIn 0.44940788
hib 0.020680824
itors 0.030567529
: 1.7335006
Ċ 0.7206106
A 3.1303937
. 0.2844702
ĠMechan 5.0479136
ism 0.2650406
Ġof 0.5786654
ĠAction 0.14995813
: 0.9056353
Ċ 0.16813177
Imm 1.390392
une 0.50198686
Ġcheckpoint 0.040756654
Ġinhibitors 0.099669494
, 2.9425082
Ġsuch 2.837065
Ġas 0.0036613226
Ġp 4.3967676
emb 0.39717385
rol 0.0076517197
iz 0.00296426
um 0.0015899183
ab 0.00060333364
Ġand 1.3426508
Ġn 4.3682857
iv 0.040287968
ol 0.22106972
um 0.0036892598
ab 0.003500886
, 0.10678668
Ġaim 5.7022915
Ġto 0.015566258
Ġenhance 5.6773324
Ġthe 0.5061316
Ġbody 4.103359
's 0.42527777
Ġimmune 1.72147
Ġresponse 0.73601323
Ġagainst 1.8718152
Ġmelan 2.9336998
oma 0.031097647
Ġcells 1.6709976
Ġby 1.1967432
Ġblocking 1.7071675
Ġthe 0.9982633
Ġsupp 10.55189
ressive 0.0027901295
Ġsignals 6.225167
Ġimposed 8.978748
Ġby 0.15412259
Ġspecific 4.996483
Ġimmune 2.6889021
Ġcheckpoints 2.8787608
, 2.42689
Ġlike 4.974055
ĠPD 5.3253584
- 0.23981617
1 0.17592727
/ 3.529386
PD 1.0136528
- 0.052165534
L 0.22065106
1 0.032584056
Ġand 1.7994304
ĠCT 6.321614
LA 0.25490165
- 0.78370184
4 0.023503242
. 0.65164405
Ċ 1.7338125
B 2.5863469
. 0.004525909
ĠEffect 5.1057057
iveness 0.388198
Ġand 2.642178
ĠLong 4.753847
- 0.29482925
term 0.992032
ĠRem 9.311095
ission 1.3573687
: 0.10031103
Ċ 0.013509974
Research 4.8018913
Ġhas 1.4052911
Ġshown 0.82939863
Ġsubstantial 9.0643635
Ġpromise 4.4484506
Ġin 1.0419079
Ġimmune 8.483565
Ġcheckpoint 0.019747756
Ġinhibitors 0.7240313
, 1.5650849
Ġleading 5.2321134
Ġto 0.2936036
Ġimpressive 5.4498577
Ġresponse 5.957581
Ġrates 0.06250427
Ġand 1.8330846
Ġdurable 4.90878
, 4.2498684
Ġlong 0.8117485
- 0.027292347
term 0.22982593
Ġremission 1.4097604
Ġin 2.0423343
Ġpatients 0.6622025
Ġwith 0.90880334
Ġadvanced 1.7353759
Ġmelan 0.28240472
oma 0.01727282
. 0.3023295
ĠClinical 5.15049
Ġtrials 0.54586273
Ġdemonstrated 6.329465
Ġa 2.4642553
Ġsignificant 1.6512178
Ġsurvival 5.074361
Ġadvantage 0.9639561
Ġfor 1.4298245
Ġpatients 0.26097855
Ġtreated 0.6744041
Ġwith 0.033642158
Ġp 1.5570204
emb 0.0032512543
rol 0.004158882
iz 0.00015040733
um 4.1200903e-05
ab 0.00017031706
Ġand 1.617785
Ġn 0.3220399
iv 0.00019368572
ol 0.0010983546
um 0.00016388074
ab 0.00015851353
Ġcompared 1.8167821
Ġto 0.4470424
Ġtraditional 7.2178607
Ġtherapies 2.1988025
. 0.9254096
Ċ 1.7495869
C 1.8504595
. 0.0037164213
ĠImpl 5.298408
ications 0.0104812775
Ġfor 0.27289477
ĠPatients 1.7510352
Ġat 1.320906
ĠDifferent 0.11918839
ĠSt 0.40616533
ages 2.6538237e-05
: 1.7860125
Ċ 0.00959637
1 3.7613173
. 0.114620276
ĠAdvanced 6.1276593
ĠMel 3.5343254
an 0.0014226555
oma 0.012039572
: 0.3949218
ĠImm 9.533667
une 0.0014937479
Ġcheckpoint 0.12810194
Ġinhibitors 0.13329269
Ġhave 1.4469855
Ġproven 2.7760854
Ġparticularly 4.3919196
Ġeffective 1.1101325
Ġin 0.4104119
Ġpatients 0.6612699
Ġwith 0.5014784
Ġadvanced 0.58424795
Ġor 4.250329
Ġmetast 0.4913457
atic 0.0037460357
Ġmelan 0.17415904
oma 0.025316305
, 1.4510689
Ġachieving 6.8097014
Ġhigher 5.6441536
Ġresponse 1.6497263
Ġrates 0.020581216
Ġand 1.1308765
Ġsuperior 5.0163536
Ġoverall 3.4280434
Ġsurvival 0.085158184
Ġcompared 2.0844338
Ġto 0.047308397
Ġstandard 2.3501909
Ġtreatments 2.3795269
. 0.19537976
Ċ 0.88530004
2 0.16791204
. 0.0019975721
ĠEarly 2.8897066
- 2.3410368
stage 1.2705617
ĠMel 0.3198477
an 0.00063207984
oma 0.006672585
: 0.035568908
ĠStudies 4.9002666
Ġare 5.136659
Ġunderway 2.513316
Ġto 0.24028553
Ġinvestigate 2.9174466
Ġthe 0.5544975
Ġpotential 1.4890765
Ġrole 3.1971662
Ġof 0.06445865
Ġimmune 0.3777196
Ġcheckpoint 0.016546221
Ġinhibitors 0.06841774
Ġin 0.12893991
Ġadj 7.6076865
u 0.17291805
vant 0.0015062245
Ġtherapy 0.6192683
Ġsettings 8.114943
, 1.337218
Ġwhich 2.8442335
Ġmay 1.6839967
Ġimprove 3.1410093
Ġoutcomes 3.15481
Ġand 2.5033445
Ġreduce 2.2580335
Ġrec 3.1104708
urrence 0.085329734
Ġrates 0.8894397
Ġin 1.987598
Ġpatients 0.547464
Ġwith 0.40868548
Ġearlier 5.801124
Ġstages 1.5321237
Ġof 0.017693711
Ġmelan 0.6031216
oma 0.0027460195
. 0.08988544
Ċ 0.16786087
II 3.8891904
. 0.0021599764
ĠAd 1.7334905
ju 0.015049026
vant 0.054332048
ĠTher 0.44003984
ap 0.01674882
ies 0.0003032094
: 0.09830152
Ċ 0.026083384
A 0.19420592
. 0.0036598877
ĠComb 8.049759
ination 0.2818541
ĠTher 1.9439533
ap 0.010633439
ies 0.00055746926
: 0.03789954
Ċ 0.14444767
Comb 1.1577785
inations 3.6713274
Ġof 0.21120107
Ġimmune 0.6568109
Ġcheckpoint 0.0066956854
Ġinhibitors 0.077009216
Ġwith 1.918716
Ġother 1.4009424
Ġadj 1.8914528
u 0.49503905
vant 0.0022890107
Ġtherapies 0.21544641
, 1.8712518
Ġsuch 0.45085558
Ġas 0.0003103619
Ġtargeted 4.7907104
Ġtherapies 0.4562359
Ġor 1.9984046
Ġradi 4.0172753
otherapy 0.018475551
, 0.09605449
Ġshow 5.875015
Ġpotential 4.1312475
Ġin 2.6076584
Ġimproving 1.167408
Ġtreatment 3.6675584
Ġoutcomes 0.6550296
Ġand 1.3377709
Ġpreventing 3.5377939
Ġtumor 5.2721143
Ġrelapse 2.2037354
. 0.5561954
Ċ 0.4690095
B 0.8039843
. 0.00066339417
ĠEffect 6.206773
iveness 0.090693064
Ġin 2.3232627
ĠRed 6.7143307
ucing 0.01668409
ĠRec 1.6365075
urrence 0.017733997
: 1.1668478
Ċ 0.1525149
Cl 4.684297
inical 0.1870928
Ġtrials 0.3673339
Ġhave 0.83041275
Ġillustrated 8.538901
Ġthe 1.8652718
Ġeffectiveness 2.9425619
Ġof 0.058085907
Ġadj 1.2987133
u 0.0715367
vant 0.00048477546
Ġtherapies 0.3854285
Ġin 0.3497106
Ġsignificantly 6.537158
Ġreducing 0.27181786
Ġthe 1.2714531
Ġrisk 2.20881
Ġof 0.09520029
Ġrec 0.99745053
urrence 0.0058151395
Ġin 1.2125558
Ġpatients 0.32047236
Ġwith 0.10248256
Ġhigh 5.6285
- 0.1950792
risk 0.41378292
Ġmelan 1.9433511
omas 2.177265
Ġafter 6.108231
Ġsurgical 4.140357
Ġremoval 2.312178
. 0.60767317
Ċ 0.49096873
C 1.1097827
. 0.002182915
ĠImpl 2.6539705
ications 0.0036769945
Ġfor 0.06645887
ĠPatients 0.3866836
Ġat 0.24592264
ĠDifferent 0.017629161
ĠSt 0.030281933
ages 3.2140102e-05
: 0.13095033
Ċ 0.011814338
1 0.1754892
. 0.0016240681
ĠIntermediate 6.6776133
Ġto 3.53578
ĠHigh 3.511146
- 0.33760443
risk 1.2231736
ĠMel 0.2591048
an 0.0017145193
oma 0.028406372
: 0.020935573
ĠAd 3.304636
ju 0.017114615
vant 0.048478585
Ġtherapies 0.3774274
Ġhave 1.2914667
Ġshown 1.3841277
Ġpromising 2.2744033
Ġresults 1.0468549
Ġin 0.14984839
Ġimproving 2.5355186
Ġsurvival 0.92645216
Ġrates 0.4693957
Ġand 1.0262738
Ġprolong 3.5561192
ing 0.0013588498
Ġremission 4.425257
Ġin 0.44845244
Ġpatients 0.16617292
Ġat 2.9967196
Ġintermediate 0.68968564
Ġto 0.40327963
Ġhigh 0.026499307
- 0.13815519
risk 0.0023650057
Ġstages 0.25015843
Ġof 0.19673768
Ġmelan 0.20436731
oma 0.0034692478
, 2.430358
Ġreducing 5.1810446
Ġthe 1.0981137
Ġchances 6.3683314
Ġof 0.058980215
Ġrec 0.7313423
urrence 0.0042023347
Ġand 1.5841159
Ġdisease 6.1278963
Ġprogression 0.66271836
. 0.26255655
Ċ 0.07782757
2 0.095586576
. 0.0006883838
ĠLow 3.3715477
- 0.08296964
risk 0.36383203
ĠMel 0.16369213
an 0.00040785116
oma 0.013285795
: 0.028937621
ĠThe 3.1712022
Ġrole 3.9678905
Ġof 0.020694029
Ġadj 0.21336924
u 0.026766075
vant 0.00016328375
Ġtherapies 0.1918207
Ġin 0.33289877
Ġlow 2.8076868
- 0.00828454
risk 0.012165602
Ġmelan 0.7722835
oma 0.2225936
Ġis 1.36207
Ġnot 2.3308194
Ġyet 1.0527704
Ġwell 2.3416433
- 2.181072
established 1.3534132
. 0.6199694
ĠMore 5.5512424
Ġresearch 1.0285394
Ġis 0.2768211
Ġneeded 0.24866134
Ġto 0.23721933
Ġdetermine 1.185117
Ġtheir 1.9276023
Ġpotential 2.4592855
Ġbenefits 2.352155
Ġin 1.6076357
Ġthis 1.7008313
Ġpatient 2.3011484
Ġpopulation 0.21864742
. 0.105081536
Ċ 0.08738021
III 0.4208133
. 0.0015549365
ĠImpl 5.1959805
ications 0.0059130453
Ġfor 0.054960374
ĠSurvival 5.6711607
ĠRates 0.3920065
Ġand 3.389181
ĠMr 11.538083
. 0.019299686
ĠB 0.027004436
's 0.9914708
ĠCase 1.6303881
: 0.3489161
Ċ 0.03441757
A 0.9888591
. 0.0062287757
ĠImpact 3.0383332
Ġon 0.1732507
ĠSurvival 0.8016537
ĠRates 0.2114414
: 0.070562474
Ċ 0.3672313
The 2.309232
Ġintroduction 5.9390345
Ġof 0.026834399
Ġimmune 0.88146126
Ġcheckpoint 0.0026756143
Ġinhibitors 0.05011109
Ġand 1.9495414
Ġadj 0.0611928
u 0.17756934
vant 0.00075775385
Ġtherapies 0.101428166
Ġhas 1.2847697
Ġsignificantly 2.450238
Ġenhanced 4.814714
Ġsurvival 0.83291906
Ġrates 0.18533103
Ġin 0.7053394
Ġpatients 0.33766142
Ġwith 0.061215363
Ġadvanced 0.22229771
Ġmelan 0.45073536
oma 0.0136225335
. 0.4189231
ĠThese 3.3890796
Ġtreatments 1.8449525
Ġoffer 4.335626
Ġnew 4.7602167
Ġhope 1.5403568
Ġfor 0.4618585
Ġlong 6.037195
- 0.035847872
term 0.041917503
Ġremission 4.7125974
. 2.5676546
Ċ 0.53873265
B 0.49494827
. 0.00040522762
ĠMr 8.348892
. 0.0026310293
ĠB 0.0066700047
's 0.17734647
ĠCase 0.18890847
: 0.13032538
Ċ 0.105002224
Mr 1.4018365
. 0.011660492
ĠB 0.018395348
, 2.0033288
Ġdiagnosed 6.2588267
Ġwith 0.25006062
Ġadvanced 0.5304298
Ġmelan 0.19979034
oma 0.0016663986
, 1.7999951
Ġexempl 8.935067
ifies 0.024817834
Ġthe 0.43671817
Ġpotential 1.651966
Ġof 1.5175946
Ġimmune 0.7979053
Ġcheckpoint 0.004261475
Ġinhibitors 0.093416475
Ġto 2.2484026
Ġachieve 5.462139
Ġremission 3.956221
. 2.2677317
ĠWith 4.650729
Ġp 4.2157283
emb 0.0041700713
rol 0.0050845817
iz 0.0004210298
um 3.655083e-05
ab 0.00021383668
Ġtreatment 2.8302248
, 0.33233842
Ġhis 1.7228067
Ġtumor 2.5398443
Ġshr 3.4511676
inks 5.312881
Ġsignificantly 3.3691082
, 0.870082
Ġleading 3.9167979
Ġto 0.051902074
Ġincreased 4.775569
Ġoverall 2.84203
Ġsurvival 0.11496164
Ġand 1.3432758
Ġquality 5.9448853
Ġof 0.1623671
Ġlife 0.006566143
. 0.23380455
Ċ 1.1228535
Conclusion 3.9396281
: 0.037761558
Ċ 0.123264134
The 2.203136
Ġadvancements 6.3705463
Ġin 0.43412846
Ġimmune 1.2729036
Ġcheckpoint 0.008659395
Ġinhibitors 0.12999603
Ġand 0.6921133
Ġadj 0.03017252
u 0.078273654
vant 0.0006264733
Ġtherapies 0.12257119
Ġhave 1.1015532
Ġrevolution 4.7639637
ized 0.011142372
Ġmelan 3.7048688
oma 0.0038061065
Ġtreatment 0.4316146
, 1.5350884
Ġoffering 4.701675
Ġimproved 4.5155263
Ġsurvival 0.89851546
Ġrates 0.42753837
Ġand 0.38117802
Ġthe 4.7752914
Ġpotential 2.0536883
Ġfor 0.9023238
Ġlong 2.8849196
- 0.018374644
term 0.028052913
Ġremission 1.0799656
. 0.46404386
ĠThese 2.8552086
Ġtreatments 1.0744692
Ġhave 2.0322795
Ġshown 3.681804
Ġparticular 6.3511677
Ġefficacy 4.9289126
Ġin 0.22958983
Ġpatients 1.8936497
Ġwith 0.2618959
Ġadvanced 0.16249788
Ġmelan 0.52537
oma 0.015410383
, 0.6800767
Ġwhile 4.0948696
Ġongoing 7.4420366
Ġresearch 1.1393869
Ġexplores 6.0247397
Ġtheir 0.7053025
Ġbenefits 4.037724
Ġfor 1.7084666
Ġpatients 0.4497537
Ġat 0.94749445
Ġearlier 3.2879474
Ġstages 0.02086893
. 5.16995
ĠThe 3.2085645
Ġcase 2.4335563
Ġof 0.1356289
ĠMr 0.07025774
. 0.030731378
ĠB 0.0056222905
Ġfurther 3.6276278
Ġdemonstrates 2.3280551
Ġthe 0.41714728
Ġprofound 6.4861875
Ġimpact 0.6511691
Ġthese 1.1374292
Ġtherapies 1.6071459
Ġcan 0.77095866
Ġhave 0.025010813
Ġon 0.25524658
Ġpatients 1.6952057
' 2.1096287
Ġlives 1.2280834
, 1.7586879
Ġinspiring 5.732057
Ġhope 0.8152292
Ġfor 0.5097979
Ġa 1.6061747
Ġbrighter 1.7745255
Ġfuture 0.052549616
Ġin 2.8843114
Ġmelan 1.1419841
oma 0.010064854
Ġmanagement 4.9980984
. 0.15025498
